Hillsdale Investment Management Inc. Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hillsdale Investment Management Inc. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 699 shares of the medical equipment provider’s stock after purchasing an additional 200 shares during the period. Hillsdale Investment Management Inc.’s holdings in Intuitive Surgical were worth $365,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. State Street Corp increased its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. FMR LLC increased its position in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Geode Capital Management LLC raised its stake in Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after acquiring an additional 143,440 shares during the last quarter. Fisher Asset Management LLC lifted its position in Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after acquiring an additional 86,488 shares during the period. Finally, Wellington Management Group LLP grew its stake in shares of Intuitive Surgical by 1.7% in the 3rd quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock valued at $1,530,318,000 after purchasing an additional 53,383 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $508.58 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a fifty day moving average of $561.62 and a two-hundred day moving average of $532.25. The company has a market capitalization of $181.15 billion, a price-to-earnings ratio of 79.34, a PEG ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ISRG shares. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.